Life Sciences

Article

The Future of Health leaves no one behind

In the “Age of With”, an era where humans and machines collaborate and augment one another, it is more important than ever that technological advancement and human values intertwine.

Analysis

Investment in eye health to prevent sight loss

Investment in eye health to prevent sight loss – presents an in-depth comparison of publicly available data to understand the relationship between investment in eye health and eye outcomes across eight high-income and two low-medium-income countries.

Article

The Future of Health in Europe

How technology and prevention will drive more equitable and sustainable outcomes for all

To ensure citizens’ future health and well-being, Europe will need to chart a new, cost-effective and sustainable approach to healthcar

Article

Commercial Operations in Life Sciences

Driving simplification and efficiency across Commercial Operations

Digital transformation of commercial operations has transitioned from a “nice-to-have” enabler to a “must-have” capability, making it critical for Life Science companies to evaluate how digital tools will deliver customer centricity and service innovation across the commercial operations value chain

Perspectives

AI in Drug Discovery

Over the past 50 years, drug discovery has focused largely on high-throughput screening for known disease-associated targets. This makes drug discovery a long, expensive and largely unsuccessful process.

Perspectives

Intelligent biopharma

Forging the links across the value chain

The biopharmaceutical sector is facing digital disruption from multiple sources, the chief among them being artificial intelligence (AI) and cloud. Deloitte predicts that in 2019/2020, all industries will accelerate their use of cloud-based AI software and services, including biopharma companies.

Article

Intelligent drug supply chain

Creating value from AI

Protecting biopharma supply chains is a priority for companies ensuring access to lifesaving products.

Article

Accelerating the Future of Health

COVID-19 responses from the health ecosystem

Article

The future of health

How innovation will blur traditional health care boundaries

Article

Segmentation and growth factors of the global neuroscience market

Sizing the brain

The report breaks down the Global Neuroscience Market (GNM) across segments and geographies. It provides a comprehensive analysis of available diagnostic and treatment options – as a proxy for market size – to estimate the revenue-based valuation of the GNM until 2026.

Article

China as the digital transformation sandbox for pharma multinationals

Analysis

Pharma and the connected patient

How digital technology is enabling patient centricity

New research released by the Deloitte UK Centre for Health Solutions explores how digital technology can help pharma embrace patient centricity to remain relevant, profitable, and to deliver better health outcomes.

Article

Time to care

Securing a future for the hospital workforce in Europe

In light of rising demand, staff shortages and lack of time for hands-on-care, is the current hospital workforce model sustainable? New research released by the Deloitte UK Centre for Health Solutions explores the current state of hospital workforces across Europe and their key challenges.

Predictions

The future awakens

Life Sciences and Health Care Predictions 2022

The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models. These are some of our predictions that, if they come true, will shake up the life sciences and health care industry.